The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis.
Phil McEwanPeter D GabbJason A DavisJuan Jose Garcia SanchezC David SjöströmSalvatore BaronePavlos KashioulisMario OuwensSyd CassimatyRicardo Correa-RotterEllen BurgessDavid C WheelerHiddo J Lambers HeerspinkPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2024)
Treatment with dapagliflozin over a lifetime time horizon may considerably delay the mean time to adverse clinical outcomes for patients who would go on to experience them, including those at modest risk of progression.
Keyphrases